289 related articles for article (PubMed ID: 29303707)
1. The influence of disease-modifying anti-rheumatic drugs and corticosteroids on the association between rheumatoid arthritis and skin cancer: a nationwide retrospective case-control study in Taiwan.
Tseng HW; Lu LY; Lam HC; Tsai KW; Huang WC; Shiue YL
Clin Exp Rheumatol; 2018; 36(3):471-478. PubMed ID: 29303707
[TBL] [Abstract][Full Text] [Related]
2. The influence of immunosuppressants on the non-melanoma skin cancer among patients with systemic lupus erythematosus and primary Sjögren's syndrome: a nationwide retrospective case-control study in Taiwan.
Tseng HW; Huang WC; Lu LY
Clin Exp Rheumatol; 2019; 37(6):946-952. PubMed ID: 31074727
[TBL] [Abstract][Full Text] [Related]
3. Risk and severity of herpes zoster in patients with rheumatoid arthritis receiving different immunosuppressive medications: a case-control study in Asia.
Liao TL; Chen YM; Liu HJ; Chen DY
BMJ Open; 2017 Jan; 7(1):e014032. PubMed ID: 28057661
[TBL] [Abstract][Full Text] [Related]
4. Disease-modifying anti-rheumatic drugs and non-melanoma skin cancer in inflammatory arthritis patients: a retrospective cohort study.
Lange E; Blizzard L; Venn A; Francis H; Jones G
Rheumatology (Oxford); 2016 Sep; 55(9):1594-600. PubMed ID: 27185957
[TBL] [Abstract][Full Text] [Related]
5. Analysis of non-melanoma skin cancer across the tofacitinib rheumatoid arthritis clinical programme.
Curtis JR; Lee EB; Martin G; Mariette X; Terry KK; Chen Y; Geier J; Andrews J; Kaur M; Fan H; Nduaka CI
Clin Exp Rheumatol; 2017; 35(4):614-622. PubMed ID: 28240592
[TBL] [Abstract][Full Text] [Related]
6. Biologic treatment for rheumatic disease: real-world big data analysis from the Greek country-wide prescription database.
Sfikakis PP; Bournia VK; Sidiropoulos P; Boumpas DT; Drosos AA; Kitas GD; Konstantonis G; Liossis SN; Manoussakis MN; Sakkas L; Tektonidou M; Tzioufas AG; Vlachoyiannopoulos PG; Kani C; Paterakis P; Litsa P; Vassilopoulos D
Clin Exp Rheumatol; 2017; 35(4):579-585. PubMed ID: 28281458
[TBL] [Abstract][Full Text] [Related]
7. Skin cancer, rheumatoid arthritis, and tumor necrosis factor inhibitors.
Chakravarty EF; Michaud K; Wolfe F
J Rheumatol; 2005 Nov; 32(11):2130-5. PubMed ID: 16265690
[TBL] [Abstract][Full Text] [Related]
8. The risk of cancer in patients with rheumatoid arthritis taking tumor necrosis factor antagonists: a nationwide cohort study.
Wu CY; Chen DY; Shen JL; Ho HJ; Chen CC; Kuo KN; Liu HN; Chang YT; Chen YJ
Arthritis Res Ther; 2014 Sep; 16(5):449. PubMed ID: 25267341
[TBL] [Abstract][Full Text] [Related]
9. Risk of malignant melanoma and non-melanoma skin cancer in rheumatoid arthritis patients initiating methotrexate versus hydroxychloroquine: a cohort study.
Lee H; Chen SK; Gautam N; Vine SM; He M; Desai RJ; Weinblatt ME; Glynn RJ; Kim SC
Clin Exp Rheumatol; 2023 Jan; 41(1):110-117. PubMed ID: 35616586
[TBL] [Abstract][Full Text] [Related]
10. An increased risk of non-melanoma skin cancer during TNF-inhibitor treatment in psoriasis patients compared to rheumatoid arthritis patients probably relates to disease-related factors.
van Lümig PP; Menting SP; van den Reek JM; Spuls PI; van Riel PL; van de Kerkhof PC; Fransen J; Kievit W; de Jong EM
J Eur Acad Dermatol Venereol; 2015 Apr; 29(4):752-60. PubMed ID: 25229823
[TBL] [Abstract][Full Text] [Related]
11. Risk of non-melanoma skin cancer in a national cohort of veterans with rheumatoid arthritis.
Amari W; Zeringue AL; McDonald JR; Caplan L; Eisen SA; Ranganathan P
Rheumatology (Oxford); 2011 Aug; 50(8):1431-9. PubMed ID: 21415022
[TBL] [Abstract][Full Text] [Related]
12. No increased risk of herpes zoster in TNF inhibitor and non-TNF inhibitor users with rheumatoid arthritis: epidemiological study using the Japanese health insurance database.
Sakai R; Kasai S; Hirano F; Harada S; Kihara M; Yokoyama W; Tsutsumino M; Nagasaka K; Koike R; Yamanaka H; Miyasaka N; Harigai M
Int J Rheum Dis; 2018 Sep; 21(9):1670-1677. PubMed ID: 29667330
[TBL] [Abstract][Full Text] [Related]
13. The risk of herpes zoster in patients with rheumatoid arthritis in the United States and the United Kingdom.
Smitten AL; Choi HK; Hochberg MC; Suissa S; Simon TA; Testa MA; Chan KA
Arthritis Rheum; 2007 Dec; 57(8):1431-8. PubMed ID: 18050184
[TBL] [Abstract][Full Text] [Related]
14. Risk of Nonmelanoma Skin Cancer Associated With the Use of Immunosuppressant and Biologic Agents in Patients With a History of Autoimmune Disease and Nonmelanoma Skin Cancer.
Scott FI; Mamtani R; Brensinger CM; Haynes K; Chiesa-Fuxench ZC; Zhang J; Chen L; Xie F; Yun H; Osterman MT; Beukelman T; Margolis DJ; Curtis JR; Lewis JD
JAMA Dermatol; 2016 Feb; 152(2):164-72. PubMed ID: 26510126
[TBL] [Abstract][Full Text] [Related]
15. One-Year Tuberculosis Risk in Rheumatoid Arthritis Patients Starting Their First Tumor Necrosis Factor Inhibitor Therapy from 2008 to 2012 in Taiwan: A Nationwide Population-Based Cohort Study.
Lim CH; Lin CH; Chen DY; Chen YM; Chao WC; Liao TL; Chen HH
PLoS One; 2016; 11(11):e0166339. PubMed ID: 27832150
[TBL] [Abstract][Full Text] [Related]
16. Risk of venous thromboembolism in patients with rheumatoid arthritis: initiating disease-modifying antirheumatic drugs.
Kim SC; Solomon DH; Liu J; Franklin JM; Glynn RJ; Schneeweiss S
Am J Med; 2015 May; 128(5):539.e7-17. PubMed ID: 25534420
[TBL] [Abstract][Full Text] [Related]
17. Reduced Risk of Parkinson Disease in Patients With Rheumatoid Arthritis: A Nationwide Population-Based Study.
Sung YF; Liu FC; Lin CC; Lee JT; Yang FC; Chou YC; Lin CL; Kao CH; Lo HY; Yang TY
Mayo Clin Proc; 2016 Oct; 91(10):1346-1353. PubMed ID: 27712633
[TBL] [Abstract][Full Text] [Related]
18. Association Between Medications and Herpes Zoster in Japanese Patients with Rheumatoid Arthritis: A 5-year Prospective Cohort Study.
Harada S; Sakai R; Hirano F; Miyasaka N; Harigai M;
J Rheumatol; 2017 Jul; 44(7):988-995. PubMed ID: 28412701
[TBL] [Abstract][Full Text] [Related]
19. Risk of non-melanoma skin cancer for rheumatoid arthritis patients receiving TNF antagonist: a systematic review and meta-analysis.
Wang JL; Yin WJ; Zhou LY; Zhou G; Liu K; Hu C; Zuo XC; Wang YF
Clin Rheumatol; 2020 Mar; 39(3):769-778. PubMed ID: 31823140
[TBL] [Abstract][Full Text] [Related]
20. Rheumatoid arthritis, anti-tumour necrosis factor treatment, and risk of squamous cell and basal cell skin cancer: cohort study based on nationwide prospectively recorded data from Sweden.
Raaschou P; Simard JF; Asker Hagelberg C; Askling J;
BMJ; 2016 Jan; 352():i262. PubMed ID: 26823527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
